About the author
For more than 20 years, Serhat Ertan has worked in private sector organizations in foreign capital investments for several companies in various sectors in Turkey.
Among them Moore Stephens Turkey (MBK) and Roedl und Partner (R&P) are in financial consultancy and auditing sector. Petrol Ofisi (OMV) was operating in the field of energy storage and distribution. GlaxoSmithKline (GSK) was in sales of pharmaceuticals and consumer products. Ferring Pharmaceuticals was selling urology drugs. Between 2013 to 2020, he worked in the French investment Socomec Turkey as an accounting and finance manager. During Covid-19 period, he undertook the responsibility in the cost accounting department for largest solar panel manufacturer Chinese HT-SAAE Turkey. He was appointed as a foreign trade manager of Olgun Medikal medical company that operates in medical device and consumables manufacturing and wholesale trading. Currently, he is working for CIO Office at Fibabanka.
During his working life, parallel to his expertise, he completed an MBA program from Marmara University business administration in German and Maltepe University international finance management.
